Clinical Trial Update: A Phase 2b Study of Zagociguat in Patients With MELAS [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2b trial of Zagociguat for Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome), …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like Episodes

Drugs mentioned

• Zagociguat (Zagociguat)

Snippet

Sponsor: Tisento Therapeutics | Conditions: Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome) | Phase 2 | Status: ACTIVE_NOT_RECRUITING